Pages that link to "Q37392165"
Jump to navigation
Jump to search
The following pages link to Bruce Neal (Q37392165):
Displaying 50 items.
- Effects of Blood Pressure Reduction in Mild Hypertension (Q22305300) (← links)
- Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty (Q24200252) (← links)
- Salt Reduction Initiatives around the World - A Systematic Review of Progress towards the Global Target (Q26800953) (← links)
- Effects of fibrates in kidney disease: a systematic review and meta-analysis (Q27008473) (← links)
- A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. (Q27860879) (← links)
- Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis (Q28482437) (← links)
- A shortened verbal autopsy instrument for use in routine mortality surveillance systems (Q28604125) (← links)
- Improving performance of the Tariff Method for assigning causes of death to verbal autopsies (Q28606610) (← links)
- Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 (Q30358426) (← links)
- Comparability of HbA1c and lipids measured with dried blood spot versus venous samples: a systematic review and meta-analysis (Q30583919) (← links)
- Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data (Q30843316) (← links)
- Ambulatory blood pressure adds little to Framingham Risk Score for the primary prevention of cardiovascular disease in older men: secondary analysis of observational study data (Q30848584) (← links)
- Effectiveness of fixed dose combination medication ('polypills') compared with usual care in patients with cardiovascular disease or at high risk: A prospective, individual patient data meta-analysis of 3140 patients in six countries (Q31035256) (← links)
- Do polypills lead to neglect of lifestyle risk factors? Findings from an individual participant data meta-analysis among 3140 patients at high risk of cardiovascular disease (Q31053249) (← links)
- Estimating population food and nutrient exposure: a comparison of store survey data with household panel food purchases (Q31070000) (← links)
- Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS study (Q31126016) (← links)
- Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials (Q33413288) (← links)
- FoodSwitch: A Mobile Phone App to Enable Consumers to Make Healthier Food Choices and Crowdsourcing of National Food Composition Data. (Q33441522) (← links)
- Using mobile technology to support lower-salt food choices for people with cardiovascular disease: protocol for the SaltSwitch randomized controlled trial (Q33441676) (← links)
- Effects of interpretive front-of-pack nutrition labels on food purchases: protocol for the Starlight randomised controlled trial (Q33441695) (← links)
- Use of Smartphone for Verbal Autopsy (Q33450641) (← links)
- Effects of interpretive nutrition labels on consumer food purchases: the Starlight randomized controlled trial (Q33452556) (← links)
- A salt-reduction smartphone app supports lower-salt food purchases for people with cardiovascular disease: Findings from the SaltSwitch randomised controlled trial (Q33455144) (← links)
- The Sodium Content of Processed Foods in South Africa during the Introduction of Mandatory Sodium Limits. (Q33616969) (← links)
- Monitoring initial response to Angiotensin-converting enzyme inhibitor-based regimens: an individual patient data meta-analysis from randomized, placebo-controlled trials (Q33631038) (← links)
- Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst indigenous and non indigenous people at high cardiovascular risk (Q33650346) (← links)
- Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trials (Q33835824) (← links)
- Follow-up of blood-pressure lowering and glucose control in type 2 diabetes (Q34042084) (← links)
- Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial. (Q34222530) (← links)
- Impact of blood pressure lowering on cardiovascular outcomes in normal weight, overweight, and obese individuals: the Perindopril Protection Against Recurrent Stroke Study trial (Q34222639) (← links)
- Comparison of waist-to-hip ratio and other obesity indices as predictors of cardiovascular disease risk in people with type-2 diabetes: a prospective cohort study from ADVANCE. (Q34222714) (← links)
- An evaluation of the effects of the Australian Food and Health Dialogue targets on the sodium content of bread, breakfast cereals and processed meats (Q34263568) (← links)
- Omega 3 Fatty acids and cardiovascular outcomes: systematic review and meta-analysis (Q34308961) (← links)
- Protocol for developing the evidence base for a national salt reduction programme for India (Q34417219) (← links)
- Comparison of near-patient capillary glucose measurement and a risk assessment questionnaire in screening for type 2 diabetes in a high-risk population in rural India (Q34421871) (← links)
- Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis (Q34462095) (← links)
- Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis (Q34501392) (← links)
- The association of knowledge, attitudes and behaviours related to salt with 24-hour urinary sodium excretion (Q34524005) (← links)
- Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trial (Q34580159) (← links)
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial (Q34630074) (← links)
- Internet-delivered cognitive behavioural therapy for adults with mild to moderate depression and high cardiovascular disease risks: a randomised attention-controlled trial (Q34650792) (← links)
- Evaluation of the dual peroxisome proliferator-activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: rationale and design of the AleCardio trial. (Q34655950) (← links)
- Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial (Q34660831) (← links)
- Impact of the UK voluntary sodium reduction targets on the sodium content of processed foods from 2006 to 2011: analysis of household consumer panel data. (Q34953871) (← links)
- Population impact of a high cardiovascular risk management program delivered by village doctors in rural China: design and rationale of a large, cluster-randomized controlled trial (Q35144775) (← links)
- Protocol for the implementation and evaluation of a community-based intervention seeking to reduce dietary salt intake in Lithgow, Australia (Q35147333) (← links)
- Population Health Metrics Research Consortium gold standard verbal autopsy validation study: design, implementation, and development of analysis datasets (Q35178959) (← links)
- Does glycemic control offer similar benefits among patients with diabetes in different regions of the world? Results from the ADVANCE trial (Q35563583) (← links)
- The Sleep Apnea cardioVascular Endpoints (SAVE) Trial: Rationale, Ethics, Design, and Progress (Q35866941) (← links)
- Protocol for a cluster-randomised trial to determine the effects of advocacy actions on the salt content of processed foods (Q35904167) (← links)